Journal home
Advance online publication
Current issue
Archive
Press releases
Free Association (blog)
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Biotechnology
Nature Cell Biology
Nature Medicine
Nature Methods
Nature Reviews Cancer
Nature Reviews Genetics
Nature Reviews Molecular Cell Biology
news@nature.com
Nature Conferences
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Genetics  9, 202 - 209 (1995)
doi:10.1038/ng0295-202

Mouse model of X−linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production

Jonathan D. Pollock1, David A. Williams1, 2, Mary A.C. Gifford1, Ling Lin Li1, Xunxiang Du1, Jason Fisherman3, Stuart H. Orkin3, 4, Claire M. Doerschuk1 & Mary C. Dinauer1

  1Herman B Wells Center for Pediatric Research, Departments of Pediatrics and of Medical and Molecular Genetics, James Whitcomb Riley Hospital for Children, Indiana University Medical Center,

  2Howard Hughes Medical Institute, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA

  3Division of Hematology/Oncology, Children's Hospital and the Dana Farber Cancer Institute, Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02115, USA

  4Howard Hughes Medical Institute, Boston, Massachusetts 02115, USA

 Correspondence should be addressed to M.C.D.

Chronic granulomatous disease (CGD) is a recessive disorder characterized by a defective phagocyte respiratory burst oxidase, life−threatening pyogenic infections and inflammatory granulomas. Gene targeting was used to generate mice with a null allele of the gene involved in X−linked CGD, which encodes the 91 kD subunit of the oxidase cytochrome b. Affected hemizygous male mice lacked phagocyte superoxide production, manifested an increased susceptibility to infection with Staphylococcus aureus and Aspergillus fumigatus and had an altered inflammatory response in thioglycollate peritonitis. This animal model should aid in developing new treatments for CGD and in evaluating the role of phagocyte−derived oxidants.in inflammation.

REFERENCES
  1. Curnutte, J. in Hematology of Infancy and Childhood (ed. Oski, F. & Nathan, D.G.) 904−977 (Saunders, Philadelphia, 1993).
  2. Jackson, H. &Cochrane, C. Leukocyte-induced tissue injury. Hematology/ Oncology Clin. N. America 2, 317−334 (1988). | ISI |
  3. Royer-Pokora, B. et al. Cloning the gene for an inherited human disorder — chronic granulomatous disease — on the basis of its chromosomal location. Nature 322, 32−38 (1986). | PubMed  | ChemPort |
  4. Dinauer, M.C., Orkin, S.H., Brown, R., Jesaitis, A.J. &Parkos, C.A. The glycoproteln encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex. Nature 327, 717−720 (1987). | Article | PubMed  | ISI | ChemPort |
  5. Teahan, C., Rowe, P., Parker, P., Totty, N. & Segal, A.W., X-linked chronic granulomatous disease gene codes for the beta-chain of cytochrome b-245. Nature 327, 720−721 (1987). | Article | PubMed  | ISI | ChemPort |
  6. Dinauer, M.C., Pierce, E.A., Bruns, G.A.P., Curnutte, J.T. & Orkin, S.H. Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autsomal recessive chronic granulomatous disease. J. clin. Invest. 86, 1729−1737 (1990). | PubMed  | ISI | ChemPort |
  7. Segal, A.W. et al. Cytochrome b-245 is a flavocytochrome containing FAD and the NADPH-binding site of the microbicidal oxidase of phagocytes. Biochem. J. 284, 781−788 (1992). | PubMed  | ISI | ChemPort |
  8. Rotrosen, D., Yeung, C.L., Leto, T.L., Malech, H.L. & Kwong, C.H. Cytochrome b558: the flavin-binding component of the phagocyte NADPH oxidase. Science 256, 1459−1462 (1992). | PubMed  | ISI | ChemPort |
  9. Dinauer, M. The respiratory burst oxidase and the molecular genetics of chronic granulomatous disease. Crit. Rev. clin. lab. Sci. 30, 329−369 (1993). | PubMed  | ISI | ChemPort |
  10. Roos, D. et al. Chronic granulomatous disease with partial deficiency of cytochrome b558 and incomplete respiratory burst: variants of the X-linked, cytochrome b558 -negative form of the disease. J. leuk. Biol. 51, 164−171 (1992). | ISI | ChemPort |
  11. Gallin, J. et al. Recent advances in chronic granulomatous disease. Ann. int. Med. 99, 657−674 (1983). | PubMed  | ISI | ChemPort |
  12. Elsbach, P. & Weiss, J. in Inflammation: basic principles and clinical correlates (eds Gallin, J., Goldstein, I. & Snyderman, R.) 603−636 (Raven Press, New York, 1992).
  13. Odell, E. & Segal, A. Killing of pathogens associated with chronic granulomatous disease by the non-oxidative microbicidal mechanisms of human neutrophils. J. med. Microbiol. 34, 129−135 (1991). | PubMed  | ISI | ChemPort |
  14. Malech, H. & Gallin, J. Current concepts: immunology. Neutrophils in human diseases. New Engl. J. Med. 317, 687−694 (1987). | PubMed  | ISI | ChemPort |
  15. Brockdorff, N., Fisher, E.M., Orkin, S.H., Lyon, M.F. & Brown, S.D. Localization of the human X-linked gene for chronic granulomatous disease to the mouse X chromosome: implications for X-chromosome evolution. Cytogenet. Cell Genet. 48, 124−125. (1988). | PubMed  | ISI | ChemPort |
  16. Baehner, R.L. & Nathan, D.G. Quantitative nitroblue tetrazolium test in chronic granulomatous disease. New Engl. J. Med. 278, 971−976 (1968). | PubMed  | ISI | ChemPort |
  17. Parkos, C.A., Allen, R.A., Cochrane, C.G. & Jesaitis, A.J. Purified cytochrome b from human granulocyte plasma membrane is comprised of two polypeptides with relative molecular weights of 91,000 and 22,000. J. clin. Invest. 80, 732−742 (1987). | PubMed  | ISI | ChemPort |
  18. Segal, A. Absence of both cytochrome b-245 subunits from neutrophils in X-linked chronic granulomatous disease. Nature 326, 88−91 (1987). | Article | PubMed  | ISI | ChemPort |
  19. Knoller, S., Shpungin, S. & Pick, E. The membrane-associated component of the amphiphile-activated, cytosol-dependent superoxide-forming NADPH oxidase of macrophages is identical to cytochrome b559.. J. biol. Chem. 266, 2795−2804 (1991). | PubMed  | ISI | ChemPort |
  20. Mayo, L. & Curnutte, J. Kinetic microplate assay for superoxide production by neutrophils and other phagocytic cells. Meth. Enzymol. 186, 567−575 (1990). | Article | PubMed  | ChemPort |
  21. Segal, A.W., Jones, O.T.G., Webster, D. & Allison, A.C. Absence of a newly described cytochrome b from neutrophils of patients with chronic granulomatous disease. Lancet ii, 446−449 (1978). | ChemPort |
  22. Parkos, C., Dinauer, M., Jesaitis, A., Orkin, S. & Curnutte, J. Absence of both the 91 kD and 22 kD subunits of human neutrophil cytochrome b in two genetic forms of chronic granulomatous disease. Blood 73, 1416−1420 (1989). | PubMed  | ISI | ChemPort |
  23. Schaffner, A. in Macrophage-Pathogen Interactions (eds Zwilling, B. & Eisenstein, T.) 545−552 (Marcel Decker, New York, 1994). | ChemPort |
  24. Schaffner, A., Douglas, H. & Braude, A. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes In resistance to aspergillus. J. clin. Invest. 60, 617−631 (1982).
  25. Diamond, R., Krzesicki, R., Epstein, B. & Jao, W. Damage to hyphal forms of fungi by human leukocytes in vitro: a possible host defense mechanism aspergillosls and mucormycosis. Am. J. Path. 91, 313−328 (1978). | PubMed  | ISI | ChemPort |
  26. Gallin, J. & Buescher, E. Abnormal regulation of inflammatory skin responses in male patients with chronic granulomatous disease. Inflammation 7, 227−232 (1983). | PubMed  | ISI | ChemPort |
  27. Xie, Q.-W. & Nathan, C. in Biological Oxidants: Generation and Injurious Consequences (eds Cochrane, C. & Glmbrone, M.J.) 213−235 (Academic, San Diego, 1992). | ChemPort |
  28. Shuster, D., Kehrli, M., Ackermann, M. & Gilbert, R. Identification and prevalence of a genetic defect that causes leukocyte adhesion deficiency in Holstein cattle. Proc. natn. Acad. Sci. U.S.A. 89, 9225−9229 (1992). | ChemPort |
  29. Padgett, E., Chediak-Higashi syndrome. Adv. Vet. Sci. 12, 239−255 (1968).
  30. Deschenes, S. et al. Comparative mapping of canine and human proximal Xq and genetic analysis of canine X-linked severe combined immunodeficiency. Genomics 23, 62−68 (1994). | Article | PubMed  | ISI | ChemPort |
  31. Deng, C. & Capecchi, M. Reexamination of gene targeting frequency as a function of the extent of homology between the targeting vector and the target locus. Molec. cell. Biol. 12, 3365−3371 (1992). | PubMed  | ISI | ChemPort |
  32. McBumey, M. et al. The mouse Pgk-1 gene promoter contains an upstream activator sequence. Nucl. Acids Res. 19, 5755−5761 (1991). | PubMed  |
  33. Pevny, L. et al. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 349, 257−260 (1991). | Article | PubMed  | ISI | ChemPort |
  34. Robertson, E.J. ed. Teratocarcinomas and Embryonic Stem Cells: A Practical Approach (IRL Press, Oxford, 1987).
  35. Zhen, L. et al. Gene targeting of X-linked chronic granulomatous disease locus in a human myeloid leukemia cell line and rescue by expression of recombinant gp91phox. Proc. natn. Acad. Sci. U.S.A. 90, 9832−9836 (1993). | ChemPort |
  36. Du, X., Neben, T., Goldman, S. & Williams, D. Effects of recombinant human interleukin-11 on hematopoietic reconstitution in transplant mice: Acceleration of recovery of peripheral blood neutrophils and platelets. Blood 81, 27−34 (1993). | PubMed  | ISI | ChemPort |
  37. Ochs, H. & Igo, R. The NBT slide test: a simple screening method for detecting chronic granulomatous disease and female carriers. J. Pediatr. 83, 77−85 (1973). | PubMed  | ISI | ChemPort |
  38. Heyworth, P.G. et al. Neutrophil nicotinamide adenine dinucleotide phosphate oxidase assembly. Translocation of p47-phox and p67-phox requires interaction between p47-phox and cytochrome b-558. J. clin. Invest. 87, 352−356 (1991). | PubMed  | ISI | ChemPort |
  39. Dinauer, M.C. et al. Point mutation in the cytoplasmic domain of the neutrophil p22-phox cytochrome b subunit is associated with a nonfunctional NADPH oxidase and chronic granulomatous disease. Proc. natn. Acad. Sci. U.S.A. 88, 11231−11235 (1991). | ChemPort |
  40. Savill, J. et al. Macrophage phagocytosis of aging neutrophils in inflammation. J. clin. Invest. 83, 865−875 (1989). | PubMed  | ISI | ChemPort |
  41. Graybill, J. & Kaster, S. Experimental murine aspergillosis: comparison of amphotericin B and a new polyene antifungal drug, SCH 28191. Am. Rev. Respir. Dis. 129, 292−295 (1984). | PubMed  | ISI | ChemPort |
  42. Dixon, D., Polak, A. & Walsh, T. Fungus dose-dependent primary pulmonary aspergillosis in immunosuppressed mice. Infect. Immun. 57, 1452−1456 (1989). | PubMed  | ISI | ChemPort |
 Top
 Top
Abstract
Previous | Next
Table of contents
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

naturejobs

References
Export citation
Export references
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Genetics
ISSN: 1061-4036
EISSN: 1546-1718
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©1995 Nature Publishing Group | Privacy policy